Taylor and Francis Group, Leukemia & Lymphoma, 5(53), p. 796-800
DOI: 10.3109/10428194.2011.639881
Full text: Unavailable
Abstract While the aetiology of multiple myeloma (MM) is largely unknown, evidence for inherited genetic susceptibility is provided by the two-fold increased risk of the disease seen in first-degree relatives of MM cases. It is likely that part of this heritable risk is a consequence of the co-inheritance of low-risk genetic variants. The accumulated experience to date, in identifying risk variants for other tumours, has highlighted difficulties in conducting statistically and methodologically rigorous studies. MAGIC (MyelomA Genetics International Consortium), includes 16 research groups in Europe, Asia, Australasia, the Middle East and the Americas engaged in studying the MM genetics. The first goal of MAGIC is to identify and characterize common genetic variants for MM through association-based analyses. Here, we review the rationale for identifying genetic risk variants for MM and our proposed strategy for establishing MAGIC.